Generalizations aren’t always the greatest, but I do feel that I’ve learned a lot from my experiences. As a geriatric/ambulatory care pharmacist, I feel that we (maybe more-so me) as pharmacists do sometimes have a blindspot. Let me explain. Throughout...
In late 2018, ACC and AHA came out with an update to their cholesterol guidelines. The last update was from 2013 so PCSK-9 inhibitors hadn’t even been approved at that time. Very High Risk Patients – My Biggest Takeaway I always had a hard time knowing...
A few months ago, we produced a study schedule for the BCPS exam and one for those seeking BCGP certification. Some of you who are looking for Ambulatory Care study help have spoken up which is greatly appreciated! Many of you have asked for a BCACP study...
P-Glycoprotein inhibitors can and do affect the concentrations of other drugs. I will be honest in that when I think about drug interactions, it isn’t the first thing that comes to mind. This gut transporter can impact clinical care and influence drug decisions....
I stumbled into an article the other day and I cannot seem to locate it again. What I do remember is 4 characteristics of high level clinicians. I believe that the group of individuals studied was primarily physicians. While the article is escaping me, there...
